<DOC>
	<DOCNO>NCT01701219</DOCNO>
	<brief_summary>This study safety efficacy ceftaroline fosamil Subjects Staphylococcus aureus Bacteremia Methicillin-Resistant Staphylococcus aureus ( MRSA ) Bacteremia persist least 72 hour vancomycin and/or daptomycin treatment .</brief_summary>
	<brief_title>Safety Efficacy Study Ceftaroline Subjects With Staphylococcus Aureus Bacteremia With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia</brief_title>
	<detailed_description>Subjects either S. aureus bacteremia persistent MRSA bacteremia treat open label ceftaroline fosamil , safety monitor clearance bacteremia evaluate .</detailed_description>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>1 . Presence bacteremia due solely : S. aureus least 1 blood culture within 72 hour begin study drug ( Cohort A ) OR MRSA baseline blood culture least 1 additional blood culture least 72 hour vancomycin and/or daptomycin treatment ( Cohort B ) . 2 . Male female ≥ 18 year age . 3 . If female childbearing potential must willing practice sexual abstinence dual method contraception treatment least 30 day last dose study drug . 4 . Expectation survival least 2 month . 1 . For subject Cohort A : previous therapy 48 hour parenteral antibiotic activity S. aureus within 72 hour positive blood culture result . 2 . For subject Cohort B : previous therapy 48 hour parenteral antibiotic activity MRSA , except vancomycin and/or daptomycin , within 72 hour positive blood culture result confirm persistence . 3 . Previous episode S. aureus bacteremia within 3 month . 4 . Known leftsided endocarditis prosthetic heart valve . 5 . Osteomyelitis prosthetic joint infection except new onset nonhardwareassociated vertebral osteomyelitis . 6 . History hypersensitivity allergic reaction βlactam antibacterial agent . 7 . Evidence significant hepatic , hematologic , immunologic impairment . 8 . Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Staphylococcus aureus bacteremia</keyword>
	<keyword>Methicillin-resistant Staphylococcus aureus bacteremia</keyword>
	<keyword>MRSA bacteremia</keyword>
	<keyword>Blood</keyword>
	<keyword>Adult</keyword>
	<keyword>Infections</keyword>
	<keyword>Blood Culture</keyword>
</DOC>